Richard Blumenthal

To amend the Securities Act of 1934 to require country-by-country reporting.

To amend title XXXIII of the Public Health Service Act with respect to flexibility and funding for the World Trade Center Health Program.

To protect the rights of passengers with disabilities in air transportation, and for other purposes.

To amend section 230 of the Communications Act of 1934 to reaffirm civil rights, victims’ rights, and consumer protections.

To amend the Federal Election Campaign Act of 1971 to provide for additional disclosure requirements for corporations, labor organizations, Super PACs and other entities, and for other purposes.

To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for tobacco products and electronic nicotine delivery systems.

To provide for drone security.

To amend the Employee Retirement Income Security Act of 1974 to permit retirement plans to consider certain factors in investment decisions.

To codify the existing Outdoor Recreation Legacy Partnership Program of the National Park Service, and for other purposes.

To protect consumers from price-gouging of gasoline and other fuels, and for other purposes.

To establish the Office of the Special Investigator for Competition Matters within the Department of Agriculture.

To modify the disposition of certain outer Continental Shelf revenues and to open Federal financial sharing to heighten opportunities for renewable energy, and for other purposes.

To amend the Internal Revenue Code of 1986 to provide for current year inclusion of net CFC tested income, and for other purposes.

To amend title 28, United States Code, to provide for a code of conduct for justices of the Supreme Court of the United States, and for other purposes.

To regulate large capacity ammunition feeding devices.

To improve protections for meatpacking workers, and for other purposes.

To extend Federal Pell Grant eligibility of certain short-term programs.

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.

To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.

To amend the Tibetan Policy Act of 2002 to modify certain provisions of that Act.